• Home
  • Dosimetric implications of residual seminal vesicle motion in fiducial-guided intensity-modulated radiotherapy for prostate cancer.

Dosimetric implications of residual seminal vesicle motion in fiducial-guided intensity-modulated radiotherapy for prostate cancer.

Author List
Stenmark MH, Vineberg K, Ten Haken RK, Hamstra DA, Feng M
Publication
Medical dosimetry : official journal of the American Association of Medical Dosimetrists
Publication ID (Profile URL)
https://researcherprofiles.org/profile/1159201
Publication Year
2011
PubMed ID
22189029
Publication Title
Stenmark MH, Vineberg K, Ten Haken RK, Hamstra DA, Feng M. Dosimetric implications of residual seminal vesicle motion in fiducial-guided intensity-modulated radiotherapy for prostate cancer. Med Dosim. 2012; 37(3):240-4.